Stock comparison
AdaptHealth
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
AHCO
AdaptHealth
Market cap
$1.42B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | AHCO | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 36D | 77B | LMAT |
| Benjamin Graham | 21F | 89A | LMAT |
| Philip Fisher | 26F | 81C | LMAT |
| Peter Lynch | 30F | 67B | LMAT |
| Joel Greenblatt | 24F | 56D | LMAT |
| Charlie Munger | 27F | 68D | LMAT |
| Terry Smith | 19F | 69D | LMAT |
Side-by-side metrics
| Metric | AHCO | LMAT |
|---|---|---|
| Market cap | $1.42B | $2.23B |
| P/E (TTM) | - | 37.1x |
| EV/EBIT | 18.7x | 36.6x |
| ROIC (TTM) | 5.52% | 9.43% |
| Gross margin | 5.38% | 72.39% |
| Net margin | -2.78% | 24.35% |
| Revenue CAGR 5y | 7.23% | 12.75% |
| EPS CAGR 5y | - | 19.04% |
| Debt / Equity | 1.3x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AHCO leads on
- P/E (TTM)-vs 37.1x+152%
- EV/EBIT18.7xvs 36.6x+49%
LMAT leads on
- Net margin24.35%vs -2.78%+111%
- Dividend yield0.84%vs 0.0%+100%
- Gross margin72.39%vs 5.38%+93%
- Debt / Equity0.5xvs 1.3x+65%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.